- Home
- IMAB vs DMA Comparison
IMAB vs DMA Comparison
Compare IMAB & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- DMA
- Stock Information
- Founded
- IMAB 2014
- DMA 2011
- Country
- IMAB United States
- DMA United States
- Employees
- IMAB N/A
- DMA N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- DMA Trusts Except Educational Religious and Charitable
- Sector
- IMAB Health Care
- DMA Finance
- Exchange
- IMAB Nasdaq
- DMA Nasdaq
- Market Cap
- IMAB 73.9M
- DMA 72.0M
- IPO Year
- IMAB 2020
- DMA N/A
- Fundamental
- Price
- IMAB $0.89
- DMA $8.43
- Analyst Decision
- IMAB Strong Buy
- DMA
- Analyst Count
- IMAB 2
- DMA 0
- Target Price
- IMAB $5.50
- DMA N/A
- AVG Volume (30 Days)
- IMAB 220.3K
- DMA 34.6K
- Earning Date
- IMAB 04-03-2025
- DMA 01-01-0001
- Dividend Yield
- IMAB N/A
- DMA 2.04%
- EPS Growth
- IMAB N/A
- DMA N/A
- EPS
- IMAB N/A
- DMA N/A
- Revenue
- IMAB N/A
- DMA N/A
- Revenue This Year
- IMAB N/A
- DMA N/A
- Revenue Next Year
- IMAB N/A
- DMA N/A
- P/E Ratio
- IMAB N/A
- DMA N/A
- Revenue Growth
- IMAB N/A
- DMA N/A
- 52 Week Low
- IMAB $0.60
- DMA $4.78
- 52 Week High
- IMAB $2.00
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- IMAB 54.14
- DMA 56.60
- Support Level
- IMAB $0.85
- DMA $8.25
- Resistance Level
- IMAB $0.97
- DMA $8.63
- Average True Range (ATR)
- IMAB 0.06
- DMA 0.21
- MACD
- IMAB 0.01
- DMA 0.05
- Stochastic Oscillator
- IMAB 56.71
- DMA 78.69
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.